Medication Brand Name:

Relistor

 
Active Ingredient:
methylnaltrexone bromide
 
DIN(s) in Canada:
02308215
 
francais
Manufacturer/Distributor:
Wyeth Canada
 
DrugCoverage Category:
Constipation
 
See Also:


Relistor is an eligible benefit through most private insurance plans and is being reviewed for funding by provincial/ territorial programs and federal plans. Reimbursement through special authorization mechanisms or through palliative care programs may also be available for Relistor through some provincial/ territorial programs. For more detailed information (including reimbursement criteria, guidelines, claim forms) click HERE.

Product Monograph
 
Coverage/Reimbursement by Private Insurance Plans in Canada
RELISTOR may be covered by private insurance plans. Some plans require special authorization / prior authorization before granting reimbursement. For more detailed information (including reimbursement criteria, guidelines, claim forms) click HERE.
 
Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province Coverage Program / Eligibility Criteria
Alberta AB Under Review Relistor is currently under review by Alberta Health and Wellness
British Columbia BC Under Review Relistor is currently under review by B.C. Pharmacare
Manitoba MB Under Review Relistor is currently under review by Manitoba Pharmacare
New Brunswick NB Not Covered Relistor is not currently covered by the New Brunswick Prescription Drug Program (NBPDP)
Newfoundland & Labrador NL Not Covered Relistor is not currently covered by the Newfoundland and Labrador Prescription Drug Program (NLPDP)
Northwest Territories NT Under Review Relistor is currently under review by the Northwest Territories Health Benefits Program
Nova Scotia NS Not Covered Relistor is not currently covered by Nova Scotia Pharmacare
Nunavut NU Under Review Relistor is currently under review by Nunavut Health and Social Programs
Ontario ON Under Review Relistor is currently under review by the Ontario Drug Benefit Program / Trillium Drug Program
Prince Edward Island PE Under Review Relistor is currently under review by the Prince Edward Island Drug Cost Assistance Program
Quebec QC Not Covered Relistor is not currently covered by the RAMQ.
Saskatchewan SK Not Covered Relistor is not currently covered by the Saskatchewan Health
Yukon Territory YT Under Review Relistor is currently under review by Yukon Pharmacare
 
Coverage/Reimbursement by Canadian Federal Plans
Plan Coverage Program / Eligibility Criteria
Public Services Health Care Plan Covered Relistor is covered by The PSHCP
Non-Insured Health Benefits Under Review Relistor is under review by the NIHB
Veterans Affairs Canada Under Review Relistor is under review by Veterans Affairs Canada
Canadian Forces Health Services Under Review Relistor is under review by the Canadian Forces Health Services
Interim Federal Health Program Under Review Relistor is under review by the Interim Federal Health Program
 
Health Canada Drug Product Database Listing